Protein-Polymer Conjugation Techniques in Drug Delivery Systems

Protein-polymer conjugation represents a versatile strategy to improve the pharmacokinetic and pharmacodynamic profiles of biologically active proteins. By covalently linking synthetic or genetically encoded polymers to a protein scaffold, researchers can extend circulatory half-lives, reduce immunogenicity and tailor biodistribution. Common approaches include PEGylation, genetic fusion to unstructured polypeptides (such as elastin-like or PAS sequences) and site-specific bioorthogonal chemistries that exploit engineered amino acid residues. These conjugation techniques permit fine control over polymer length, attachment site and conjugate architecture, enabling the formation of stimuli-responsive depots, targeted assemblies and self-organising nanostructures. Through modulation of amphiphilicity, hydrodynamic volume and surface properties, protein-polymer bioconjugates can achieve sustained release, triggered disassembly or enhanced cell uptake. Such hybrid materials find application in oncology, enzyme replacement therapy and vaccine delivery, offering a robust platform to address global challenges in therapeutic stability and dosage compliance.

Research from Nature Portfolio

Recent studies have demonstrated the power of albumin-binding ligands to extend peptide half-life via a “piggy-back” mechanism. A custom peptide-fatty acid chimera was shown to bind serum albumin with nanomolar affinity, increasing circulation times by over twenty-fold in preclinical models. Conjugation of this ligand to a cyclic anticoagulant peptide prolonged its elimination half-life from minutes to hours and sustained antithrombotic efficacy in vivo. This strategy offers a modular route to transform rapidly cleared peptides into long-acting therapeutics without compromising target potency.

Protein-Polymer Conjugation Techniques in Drug Delivery Systems publication trend

The graph below shows the total number of articles in protein-polymer conjugation techniques in drug delivery systems across all publications each year (not limited to Nature Index journals).

Technical terms

PEGylation: Attachment of polyethylene glycol chains to proteins to increase hydrodynamic size and extend half-life.

Bioorthogonal chemistry: Chemical reactions that occur selectively inside living systems without interfering with native biochemical processes.

Elastin-like polypeptide (ELP): A genetically encoded, thermoresponsive polypeptide that undergoes reversible phase transition upon temperature change.

Self-assembly: Spontaneous organisation of molecular building blocks into ordered nanostructures driven by noncovalent interactions.

Stimuli-responsive hydrogel: A crosslinked polymer network that swells or degrades in response to environmental cues such as pH or temperature.

References

1. PenTag, a Versatile Platform for Synthesizing Protein‐Polymer Biohybrid Materials. Advanced Functional Materials (2023).
2. Protein‐based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy. Angewandte Chemie International Edition (2023).
3. Thermoresponsive Polypeptide Fused L‐Asparaginase with Mitigated Immunogenicity and Enhanced Efficacy in Treating Hematologic Malignancies. Advanced Science (2023).
4. Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides. Nature Communications (2017).